Lindsay Anne Sceats
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lindsay Anne Sceats has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Cindy Kin
Department of Surgery, Section of Colon and Rectal Surgery, Stanford University School of Medicine, Stanford, California
4 shared publications Cindy Kin
Stanford-Surgery Policy Improvement Research and Education (S-SPIRE) Center, Department of Surgery, Stanford University, Stanford, California
2 shared publications- David A. Spain
Department of Surgery, Stanford University, Stanford, California, USA
2 shared publications A. M. Morris
Department of Surgery, S-SPIRE Center, Stanford University School of Medicine, Stanford, California, USA
1 shared publicationAlaleh Esmaeili Shandiz
Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive Rm H2210, Stanford, CA, 94305, USA
1 shared publicationAlanna Coughran
School of Medicine, Stanford University, Stanford, California
1 shared publication
Latest Publications
- Open Access
- 19 February 2021
- Published by BMJ in Trauma Surgery & Acute Care Open
- Vol. 6 (1) , e000693
Management of splenic platelet sequestration in idiopathic thrombocytopenic purpura
A patient in their 40s presented to the emergency department with 3 weeks of diffuse itching, epistaxis, oral ulcers, gum bleeding, petechiae and ecchymoses (figure 1). Medical history was notable for hypertension. The patient denied any recent illnesses, new medications or recent vaccinations. The patient denied any B symptoms including fevers, night sweats or weight loss. Family history was notable for a maternal cousin and uncle with thrombocytopenia requiring intervention.
- 19 February 2021
- Published by BMJ in Trauma Surgery & Acute Care Open
- Vol. 6 (1) , e000693
Open AccessManagement of splenic platelet sequestration in idiopathic thrombocytopenic purpura
A patient in their 40s presented to the emergency department with 3 weeks of diffuse itching, epistaxis, oral ulcers, gum bleeding, petechiae and ecchymoses (figure 1). Medical history was notable for hypertension. The patient denied any recent illnesses, new medications or recent vaccinations. The patient denied any B symptoms including fevers, night sweats or weight loss. Family history was notable for a maternal cousin and uncle with thrombocytopenia requiring intervention.
- 1 January 2021
- Published by Elsevier in Journal of Surgical Education
- Vol. 78 (1) , 160-167
“It's Like Learning by the Seat of Your Pants”: Surgeons Lack Formal Training in Opioid Prescribing
- 1 January 2021
- Published by Elsevier in Journal of Surgical Education
- Vol. 78 (1) , 160-167
“It's Like Learning by the Seat of Your Pants”: Surgeons Lack Formal Training in Opioid Prescribing
- 5 December 2019
- Published by Wiley in Colorectal Disease
- Vol. 22 (5) , 544-553
Surgery, stomas, and anxiety and depression in inflammatory bowel disease: a retrospective cohort analysis of privately insured patients
Aim: Patients with inflammatory bowel disease (IBD) are diagnosed with anxiety/depression at higher rates than the general population. We aimed to determine the frequency of anxiety/depression among IBD patients and the temporal association with abdominal surgery and stoma formation.Method: We conducted a retrospective cohort study in adult patients with IBD using difference‐in‐difference methodology and a large commercial claims database (2003–2016). Outcomes were anxiety/depression diagnoses before and after major abdominal surgery or stoma formation.Results: We identified 10 481 IBD patients who underwent major abdominal surgery, 18.8% of whom underwent stoma formation, and 41 924 nonsurgical age‐ and sex‐matched IBD controls who were assigned random index dates. Rates of anxiety and depression increased among all cohorts (P < 0.001). Surgical patients had higher odds of anxiety [one surgery, adjusted OR 6.90 (95% CI 6.11–7.79), P < 0.001; two or more surgeries, 7.53 (5.99–9.46), P < 0.001] and depression [one surgery, 6.15 (5.57–6.80), P < 0.001; two or more surgeries, 6.88 (5.66–8.36), P < 0.001] than nonsurgical controls. Undergoing multiple surgeries was associated with a significant increase in depression from ‘pre’ to ‘post’ time periods [1.43 (1.18–1.73), P < 0.001]. Amongst surgical patients, stoma formation was independently associated with anxiety [1.40 (1.17–1.68), P < 0.001] and depression [1.23 (1.05–1.45), P = 0.01]. New ostomates experienced a greater increase in postoperative anxiety [1.24 (1.05–1.47), P = 0.01] and depression [1.19 (1.03–1.45), P = 0.01] than other surgical patients.Conclusion: IBD patients who undergo surgery have higher rates of anxiety and depression than nonsurgical patients. Rates of anxiety and depression increase following surgery. Stoma formation represents an additional risk factor. These findings suggest the need for perioperative psychosocial support services.
- 5 December 2019
- Published by Wiley in Colorectal Disease
- Vol. 22 (5) , 544-553
Surgery, stomas, and anxiety and depression in inflammatory bowel disease: a retrospective cohort analysis of privately insured patients
Aim: Patients with inflammatory bowel disease (IBD) are diagnosed with anxiety/depression at higher rates than the general population. We aimed to determine the frequency of anxiety/depression among IBD patients and the temporal association with abdominal surgery and stoma formation.Method: We conducted a retrospective cohort study in adult patients with IBD using difference‐in‐difference methodology and a large commercial claims database (2003–2016). Outcomes were anxiety/depression diagnoses before and after major abdominal surgery or stoma formation.Results: We identified 10 481 IBD patients who underwent major abdominal surgery, 18.8% of whom underwent stoma formation, and 41 924 nonsurgical age‐ and sex‐matched IBD controls who were assigned random index dates. Rates of anxiety and depression increased among all cohorts (P < 0.001). Surgical patients had higher odds of anxiety [one surgery, adjusted OR 6.90 (95% CI 6.11–7.79), P < 0.001; two or more surgeries, 7.53 (5.99–9.46), P < 0.001] and depression [one surgery, 6.15 (5.57–6.80), P < 0.001; two or more surgeries, 6.88 (5.66–8.36), P < 0.001] than nonsurgical controls. Undergoing multiple surgeries was associated with a significant increase in depression from ‘pre’ to ‘post’ time periods [1.43 (1.18–1.73), P < 0.001]. Amongst surgical patients, stoma formation was independently associated with anxiety [1.40 (1.17–1.68), P < 0.001] and depression [1.23 (1.05–1.45), P = 0.01]. New ostomates experienced a greater increase in postoperative anxiety [1.24 (1.05–1.47), P = 0.01] and depression [1.19 (1.03–1.45), P = 0.01] than other surgical patients.Conclusion: IBD patients who undergo surgery have higher rates of anxiety and depression than nonsurgical patients. Rates of anxiety and depression increase following surgery. Stoma formation represents an additional risk factor. These findings suggest the need for perioperative psychosocial support services.
- 1 October 2019
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 229 (4) , S157
Long-Term Outcomes after Nonoperative Management of Perforated Appendicitis: A Retrospective Cohort Analysis
- 1 October 2019
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 229 (4) , S157
Long-Term Outcomes after Nonoperative Management of Perforated Appendicitis: A Retrospective Cohort Analysis
- 11 July 2019
- Published by Wiley in Colorectal Disease
- Vol. 21 (12) , 1406-1414
Patient decision‐making in severe inflammatory bowel disease: the need for improved communication of treatment options and preferences
Aim: Patients with inflammatory bowel disease and their physicians must navigate ever‐increasing options for treatment. The aim of this study was to elucidate the key drivers of treatment decision‐making in inflammatory bowel disease.Methods: We conducted qualitative semi‐structured in‐person interviews of 20 adult patients undergoing treatment for inflammatory bowel disease at an academic medical centre who either recently initiated biologic therapy or underwent an operation or surgical evaluation. Interviews were audio‐recorded, transcribed verbatim, iteratively coded, and discussed to consensus by five researchers. We used thematic analysis to explore factors influencing decision‐making.Results: Four major themes emerged as key drivers of treatment decision‐making: perceived clinical state and disease severity, the patient–physician relationship, knowledge, attitudes and beliefs about treatment options, and social isolation and stigma. Patients described experiencing a clinical turning point as the impetus for proceeding with a previously undesired treatment such as infusion medication or surgery. Patients reported delays in care or diagnosis, inadequate communication with their physicians, and lack of control over their disease management. Patients often stated that they considered surgery to be the treatment of last resort, which further compounded the complexity of making treatment decisions.Conclusion: Patients described multiple barriers to making informed and collaborative decisions about treatment, especially when considering surgical options. Our study reveals a need for more comprehensive communication between the patient and their physician about the range of medical and surgical treatment options. We recommend a patient‐centred approach toward the decision‐making process that accounts for patient decision‐making preferences, causes of social stress, and clinical status.
- 11 July 2019
- Published by Wiley in Colorectal Disease
- Vol. 21 (12) , 1406-1414
Patient decision‐making in severe inflammatory bowel disease: the need for improved communication of treatment options and preferences
Aim: Patients with inflammatory bowel disease and their physicians must navigate ever‐increasing options for treatment. The aim of this study was to elucidate the key drivers of treatment decision‐making in inflammatory bowel disease.Methods: We conducted qualitative semi‐structured in‐person interviews of 20 adult patients undergoing treatment for inflammatory bowel disease at an academic medical centre who either recently initiated biologic therapy or underwent an operation or surgical evaluation. Interviews were audio‐recorded, transcribed verbatim, iteratively coded, and discussed to consensus by five researchers. We used thematic analysis to explore factors influencing decision‐making.Results: Four major themes emerged as key drivers of treatment decision‐making: perceived clinical state and disease severity, the patient–physician relationship, knowledge, attitudes and beliefs about treatment options, and social isolation and stigma. Patients described experiencing a clinical turning point as the impetus for proceeding with a previously undesired treatment such as infusion medication or surgery. Patients reported delays in care or diagnosis, inadequate communication with their physicians, and lack of control over their disease management. Patients often stated that they considered surgery to be the treatment of last resort, which further compounded the complexity of making treatment decisions.Conclusion: Patients described multiple barriers to making informed and collaborative decisions about treatment, especially when considering surgical options. Our study reveals a need for more comprehensive communication between the patient and their physician about the range of medical and surgical treatment options. We recommend a patient‐centred approach toward the decision‐making process that accounts for patient decision‐making preferences, causes of social stress, and clinical status.
- Open Access
- 1 July 2019
- Published by SAGE Publications in MDM Policy & Practice
- Vol. 4 (2)
Operative Versus Nonoperative Management of Appendicitis: A Long-Term Cost Effectiveness Analysis
Background. Recent clinical trials suggest that nonoperative management (NOM) of patients with acute, uncomplicated appendicitis is an acceptable alternative to surgery. However, limited data exist comparing the long-term cost-effectiveness of nonoperative treatment strategies. Design. We constructed a Markov model comparing the cost-effectiveness of three treatment strategies for uncomplicated appendicitis: 1) laparoscopic appendectomy, 2) inpatient NOM, and 3) outpatient NOM. The model assessed lifetime costs and outcomes from a third-party payer perspective. The preferred strategy was the one yielding the greatest utility without exceeding a $50,000 willingness-to-pay threshold. Results. Outpatient NOM cost $233,700 over a lifetime; laparoscopic appendectomy cost $2500 more while inpatient NOM cost $7300 more. Outpatient NOM generated 24.9270 quality-adjusted life-years (QALYs), while laparoscopic appendectomy and inpatient NOM yielded 0.0709 and 0.0005 additional QALYs, respectively. Laparoscopic appendectomy was cost-effective compared with outpatient NOM (incremental cost-effectiveness ratio $32,300 per QALY gained); inpatient NOM was dominated by laparoscopic appendectomy. In one-way sensitivity analyses, the preferred strategy changed when varying perioperative mortality, probability of appendiceal malignancy or recurrent appendicitis after NOM, probability of a complicated recurrence, and appendectomy cost. A two-way sensitivity analysis showed that the rates of NOM failure and appendicitis recurrence described in randomized trials exceeded the values required for NOM to be preferred. Limitations. There are limited NOM data to generate long-term model probabilities. Health state utilities were often drawn from single studies and may significantly influence model outcomes. Conclusion. Laparoscopic appendectomy is a cost-effective treatment for acute uncomplicated appendicitis over a lifetime time horizon. Inpatient NOM was never the preferred strategy in the scenarios considered here. These results emphasize the importance of considering long-term costs and outcomes when evaluating NOM.
- 1 July 2019
- Published by SAGE Publications in MDM Policy & Practice
- Vol. 4 (2)
Open AccessOperative Versus Nonoperative Management of Appendicitis: A Long-Term Cost Effectiveness Analysis
Background. Recent clinical trials suggest that nonoperative management (NOM) of patients with acute, uncomplicated appendicitis is an acceptable alternative to surgery. However, limited data exist comparing the long-term cost-effectiveness of nonoperative treatment strategies. Design. We constructed a Markov model comparing the cost-effectiveness of three treatment strategies for uncomplicated appendicitis: 1) laparoscopic appendectomy, 2) inpatient NOM, and 3) outpatient NOM. The model assessed lifetime costs and outcomes from a third-party payer perspective. The preferred strategy was the one yielding the greatest utility without exceeding a $50,000 willingness-to-pay threshold. Results. Outpatient NOM cost $233,700 over a lifetime; laparoscopic appendectomy cost $2500 more while inpatient NOM cost $7300 more. Outpatient NOM generated 24.9270 quality-adjusted life-years (QALYs), while laparoscopic appendectomy and inpatient NOM yielded 0.0709 and 0.0005 additional QALYs, respectively. Laparoscopic appendectomy was cost-effective compared with outpatient NOM (incremental cost-effectiveness ratio $32,300 per QALY gained); inpatient NOM was dominated by laparoscopic appendectomy. In one-way sensitivity analyses, the preferred strategy changed when varying perioperative mortality, probability of appendiceal malignancy or recurrent appendicitis after NOM, probability of a complicated recurrence, and appendectomy cost. A two-way sensitivity analysis showed that the rates of NOM failure and appendicitis recurrence described in randomized trials exceeded the values required for NOM to be preferred. Limitations. There are limited NOM data to generate long-term model probabilities. Health state utilities were often drawn from single studies and may significantly influence model outcomes. Conclusion. Laparoscopic appendectomy is a cost-effective treatment for acute uncomplicated appendicitis over a lifetime time horizon. Inpatient NOM was never the preferred strategy in the scenarios considered here. These results emphasize the importance of considering long-term costs and outcomes when evaluating NOM.
- 17 January 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 64 (8) , 2120-2123
Fragility of Life: Recurrent Intestinal Perforation Due to Vascular Ehlers–Danlos Syndrome
- 17 January 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 64 (8) , 2120-2123
Fragility of Life: Recurrent Intestinal Perforation Due to Vascular Ehlers–Danlos Syndrome
- 1 June 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 67 (6) , e87-E87
SS07. Association of Opioid Abuse and Peripheral Arterial Disease
- 1 June 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 67 (6) , e87-E87
SS07. Association of Opioid Abuse and Peripheral Arterial Disease